Join us on our journey to end blood cancer.
We are the only foundation in the world that supports patients with RUNX1-FPD.
Join us on our journey to
end blood cancer.
We are the only foundation in the world that supports patients with RUNX1-FPD.
What is RUNX1 Familial Platelet Disorder (RUNX1-FPD)?
First identified in 1999, RUNX1-FPD (also known as RUNX1-FPDMM, FPD-AML, or FPDMM) is a rare inherited (germline) condition caused by a variant (mutation) in the RUNX1 gene. This genetic change can be passed from one generation to the next.
Because the RUNX1 gene helps produce healthy blood cells, a variant that prevents it from working properly can lead to lower platelet counts and/or platelets that do not function as well as they should.
People with RUNX1-FPD may bruise easily, have frequent nosebleeds, or bleed longer than usual after injury or surgery.
It is important to understand that in certain circumstances, a traumatic injury can be life-threatening because of the bleeding caused by RUNX1-FPD.
The biggest concern for RUNX1-FPD patients and families is the high risk of developing blood cancer. Current estimates suggest the risk is between 35-50%. Importantly, the condition can vary greatly between families and even among family members.
People with RUNX1-FPD can also experience other health issues that are increasingly recognized as related to the disease, such as asthma, allergies, autoimmune disorders, or gastrointestinal problems.
